Treatments, NICE decisions, and future delivery methods

A trial is under way to find out if a £100 blood test could transform the way that the NHS diagnoses Alzheimer’s disease. Alzheimer’s is the leading cause of dementia and diagnosis is currently costly and time-consuming. To find out how this blood test could benefit patients, Ian Sample talks to Prof Jonathan Schott, who is co-leading the trial. He explains what the test involves and why it could pave the way for exciting new treatments for the devastating disease. Help support our independent journalism at theguardian.com/sciencepod